Cargando…

Sildenafil restores endothelial function in the apolipoprotein E knockout mouse

BACKGROUND: Atherosclerosis is an inflammatory process of the arterial walls and is initiated by endothelial dysfunction accompanied by an imbalance in the production of reactive oxygen species (ROS) and nitric oxide (NO). Sildenafil, a selective phosphodiesterase-5 (PDE5) inhibitor used for erectil...

Descripción completa

Detalles Bibliográficos
Autores principales: Balarini, Camille M, Leal, Marcos A, Gomes, Isabele B S, Pereira, Thiago M C, Gava, Agata L, Meyrelles, Silvana S, Vasquez, Elisardo C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551739/
https://www.ncbi.nlm.nih.gov/pubmed/23289368
http://dx.doi.org/10.1186/1479-5876-11-3
_version_ 1782256604615278592
author Balarini, Camille M
Leal, Marcos A
Gomes, Isabele B S
Pereira, Thiago M C
Gava, Agata L
Meyrelles, Silvana S
Vasquez, Elisardo C
author_facet Balarini, Camille M
Leal, Marcos A
Gomes, Isabele B S
Pereira, Thiago M C
Gava, Agata L
Meyrelles, Silvana S
Vasquez, Elisardo C
author_sort Balarini, Camille M
collection PubMed
description BACKGROUND: Atherosclerosis is an inflammatory process of the arterial walls and is initiated by endothelial dysfunction accompanied by an imbalance in the production of reactive oxygen species (ROS) and nitric oxide (NO). Sildenafil, a selective phosphodiesterase-5 (PDE5) inhibitor used for erectile dysfunction, exerts its cardiovascular effects by enhancing the effects of NO. The aim of this study was to investigate the influence of sildenafil on endothelial function and atherosclerosis progression in apolipoprotein E knockout (apoE(−/−)) mice. METHODS: ApoE(−/−) mice treated with sildenafil (Viagra®, 40 mg/kg/day, for 3 weeks, by oral gavage) were compared to the untreated apoE(−/−) and the wild-type (WT) mice. Aortic rings were used to evaluate the relaxation responses to acetylcholine (ACh) in all of the groups. In a separate set of experiments, the roles of NO and ROS in the relaxation response to ACh were evaluated by incubating the aortic rings with L-NAME (NO synthase inhibitor) or apocynin (NADPH oxidase inhibitor). In addition, the atherosclerotic lesions were quantified and superoxide production was assessed. RESULTS: Sildenafil restored the vasodilator response to acetylcholine (ACh) in the aortic rings of the apoE(−/−) mice. Treatment with L-NAME abolished the vasodilator responses to ACh in all three groups of mice and revealed an augmented participation of NO in the endothelium-dependent vasodilation in the sildenafil-treated animals. The normalized endothelial function in sildenafil-treated apoE(−/−) mice was unaffected by apocynin highlighting the low levels of ROS production in these animals. Moreover, morphological analysis showed that sildenafil treatment caused approximately a 40% decrease in plaque deposition in the aorta. CONCLUSION: This is the first study demonstrating the beneficial effects of chronic treatment with sildenafil on endothelial dysfunction and atherosclerosis in a model of spontaneous hypercholesterolemia. These data indicate that the main mechanism of the beneficial effect of sildenafil on the endothelial function appears to involve an enhancement of the NO pathway along with a reduction in oxidative stress.
format Online
Article
Text
id pubmed-3551739
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35517392013-01-24 Sildenafil restores endothelial function in the apolipoprotein E knockout mouse Balarini, Camille M Leal, Marcos A Gomes, Isabele B S Pereira, Thiago M C Gava, Agata L Meyrelles, Silvana S Vasquez, Elisardo C J Transl Med Research BACKGROUND: Atherosclerosis is an inflammatory process of the arterial walls and is initiated by endothelial dysfunction accompanied by an imbalance in the production of reactive oxygen species (ROS) and nitric oxide (NO). Sildenafil, a selective phosphodiesterase-5 (PDE5) inhibitor used for erectile dysfunction, exerts its cardiovascular effects by enhancing the effects of NO. The aim of this study was to investigate the influence of sildenafil on endothelial function and atherosclerosis progression in apolipoprotein E knockout (apoE(−/−)) mice. METHODS: ApoE(−/−) mice treated with sildenafil (Viagra®, 40 mg/kg/day, for 3 weeks, by oral gavage) were compared to the untreated apoE(−/−) and the wild-type (WT) mice. Aortic rings were used to evaluate the relaxation responses to acetylcholine (ACh) in all of the groups. In a separate set of experiments, the roles of NO and ROS in the relaxation response to ACh were evaluated by incubating the aortic rings with L-NAME (NO synthase inhibitor) or apocynin (NADPH oxidase inhibitor). In addition, the atherosclerotic lesions were quantified and superoxide production was assessed. RESULTS: Sildenafil restored the vasodilator response to acetylcholine (ACh) in the aortic rings of the apoE(−/−) mice. Treatment with L-NAME abolished the vasodilator responses to ACh in all three groups of mice and revealed an augmented participation of NO in the endothelium-dependent vasodilation in the sildenafil-treated animals. The normalized endothelial function in sildenafil-treated apoE(−/−) mice was unaffected by apocynin highlighting the low levels of ROS production in these animals. Moreover, morphological analysis showed that sildenafil treatment caused approximately a 40% decrease in plaque deposition in the aorta. CONCLUSION: This is the first study demonstrating the beneficial effects of chronic treatment with sildenafil on endothelial dysfunction and atherosclerosis in a model of spontaneous hypercholesterolemia. These data indicate that the main mechanism of the beneficial effect of sildenafil on the endothelial function appears to involve an enhancement of the NO pathway along with a reduction in oxidative stress. BioMed Central 2013-01-05 /pmc/articles/PMC3551739/ /pubmed/23289368 http://dx.doi.org/10.1186/1479-5876-11-3 Text en Copyright ©2013 Balarini et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Balarini, Camille M
Leal, Marcos A
Gomes, Isabele B S
Pereira, Thiago M C
Gava, Agata L
Meyrelles, Silvana S
Vasquez, Elisardo C
Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
title Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
title_full Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
title_fullStr Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
title_full_unstemmed Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
title_short Sildenafil restores endothelial function in the apolipoprotein E knockout mouse
title_sort sildenafil restores endothelial function in the apolipoprotein e knockout mouse
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551739/
https://www.ncbi.nlm.nih.gov/pubmed/23289368
http://dx.doi.org/10.1186/1479-5876-11-3
work_keys_str_mv AT balarinicamillem sildenafilrestoresendothelialfunctionintheapolipoproteineknockoutmouse
AT lealmarcosa sildenafilrestoresendothelialfunctionintheapolipoproteineknockoutmouse
AT gomesisabelebs sildenafilrestoresendothelialfunctionintheapolipoproteineknockoutmouse
AT pereirathiagomc sildenafilrestoresendothelialfunctionintheapolipoproteineknockoutmouse
AT gavaagatal sildenafilrestoresendothelialfunctionintheapolipoproteineknockoutmouse
AT meyrellessilvanas sildenafilrestoresendothelialfunctionintheapolipoproteineknockoutmouse
AT vasquezelisardoc sildenafilrestoresendothelialfunctionintheapolipoproteineknockoutmouse